In partnership with the Asian Development Bank, IVAC summarized the landscape, benefits, and challenges of next generation COVID-19 vaccines.
-
Briefs
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
Results & Summaries
This table shows the serotypes covered by the current pneumococcal conjugate vaccine products and the three additional products that are in the development pipeline.
-
Results & Summaries
This table provides a summary of studies on the duration of protection of COVID-19 vaccines. This table is updated weekly.
-
Briefs
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
Briefs
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the
-
Briefs
In partnership with the Asian Development Bank, IVAC developed factsheets summarizing key measures for COVID-19 vaccines such as effectiveness and protection against severe disease.
-
Methods
This document outlines the methods used in the COVID-19 vaccines neutralization and cellular immunity studies review.
-
VIEW-Hub Reports
The VIEW-hub report displays data and figures on the introduction, use, and coverage status of typhoid conjugate, human papillomavirus, pneumococcal, rotavirus, Haemophilus influenzae type b, and inactivated polio vaccines both globally and in the